These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35942277)

  • 21. Comparative study of the substantia nigra echogenicity and
    Mašková J; Školoudík D; Štofaniková P; Ibarburu V; Kemlink D; Zogala D; Trnka J; Krupička R; Šonka K; Růžička E; Dušek P
    Sleep Med; 2020 Jun; 70():116-123. PubMed ID: 32403038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iron accumulation and microglia activation contribute to substantia nigra hyperechogenicity in the 6-OHDA-induced rat model of Parkinson's disease.
    Zhu Y; Wang B; Tao K; Yang H; Wang Y; Zhou T; Yang Y; Yuan L; Liu X; Duan Y
    Parkinsonism Relat Disord; 2017 Mar; 36():76-82. PubMed ID: 28108264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of substantia nigra sonography in the differentiation of Parkinson's disease and multiple system atrophy.
    Zhou HY; Huang P; Sun Q; Du JJ; Cui SS; Hu YY; Zhan WW; Wang Y; Xiao Q; Liu J; Tan YY; Chen SD
    Transl Neurodegener; 2018; 7():15. PubMed ID: 30062008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognition and transcranial sonography in Parkinson's disease patients with or without orthostatic hypotension.
    Wu JJ; Jin H; Shao YQ; Mao CJ; Chen J; Liu CF
    Brain Behav; 2021 Aug; 11(8):e2252. PubMed ID: 34291604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can Quantitative Gait Analysis Be Used to Guide Treatment of Patients with Different Subtypes of Parkinson's Disease?
    Wu Z; Zhong M; Jiang X; Shen B; Zhu J; Pan Y; Dong J; Yan J; Xu P; Zhang W; Gao Y; Zhang L
    Neuropsychiatr Dis Treat; 2020; 16():2335-2341. PubMed ID: 33116532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
    Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
    J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson's Disease.
    Yilmaz R; Gräber S; Roeben B; Suenkel U; von Thaler AK; Heinzel S; Metzger FG; Eschweiler GW; Maetzler W; Berg D; Liepelt-Scarfone I
    Front Aging Neurosci; 2016; 8():271. PubMed ID: 27895578
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination of olfactory test and substantia nigra transcranial sonopraphy in the differential diagnosis of Parkinson's disease: a pilot study from China.
    Chen W; Tan YY; Hu YY; Zhan WW; Wu L; Lou Y; Wang X; Zhou Y; Huang P; Gao Y; Xiao Q; Chen SD
    Transl Neurodegener; 2012 Dec; 1(1):25. PubMed ID: 23267690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
    Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
    Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.
    Berg D; Siefker C; Becker G
    J Neurol; 2001 Aug; 248(8):684-9. PubMed ID: 11569897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association Between Clinical Characteristics and Motor Symptom Laterality in Patients With Parkinson's Disease.
    Zhu S; Zhong M; Bai Y; Wu Z; Gu R; Jiang X; Shen B; Zhu J; Pan Y; Dong J; Xu P; Yan J; Zhang L
    Front Neurol; 2021; 12():663232. PubMed ID: 34135850
    [No Abstract]   [Full Text] [Related]  

  • 36. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
    Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
    Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcranial sonography image characteristics in different Parkinson's disease subtypes.
    Sheng AY; Zhang YC; Sheng YJ; Wang CS; Zhang Y; Hu H; Luo WF; LIu CF
    Neurol Sci; 2017 Oct; 38(10):1805-1810. PubMed ID: 28726052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
    Berg D
    J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population.
    Liepelt I; Wendt A; Schweitzer KJ; Wolf B; Godau J; Gaenslen A; Bruessel T; Berg D
    J Neural Transm (Vienna); 2008 Jul; 115(7):993-9. PubMed ID: 18368284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.